Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 2

1(14.3%)

Phase 4

1(14.3%)

7Total

N/A(5)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03653455Not ApplicableActive Not Recruiting

Patient Outcomes Collection: How Can we do Better?

Role: collaborator

NCT04775004Not ApplicableActive Not Recruiting

Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)

Role: collaborator

NCT06883396Recruiting

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

Role: collaborator

NCT04519801Not ApplicableActive Not Recruiting

BFR Therapy for Post-Op Rehab of ACL Reconstruction With Quadriceps Tendon Autograft

Role: collaborator

NCT03959215Not ApplicableUnknown

Back in the Game: a Smartphone Application to Support Athletes Returning to Sport After Serious Injury

Role: collaborator

NCT01623843Not ApplicableCompleted

Femoroacetabular Impingement RandomiSed Controlled Trial

Role: collaborator

NCT02116946Phase 2Terminated

Plasma Injections Plus Exercise for Patellar Tendinopathy

Role: collaborator

NCT01557868Phase 4Completed

Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis

Role: lead

All 8 trials loaded